Multiple Sclerosis Flashcards
1
Q
What is multiple sclerosis?
A
- chronic cell-mediated autoimmune disorder
- demyelination in CNS
- more women
- 20-40yo
- higher latitudes
2
Q
Multiple sclerosis subtypes:
A
- relapsing remitting disease
- secondary progressive disease
- primary progressive disease
3
Q
Relapsing remitting multiple sclerosis:
A
- most common - 85%
- acute attacks last 1-2 months followed by periods of remission
4
Q
Secondary progressive disease multiple sclerosis:
A
- relapsing remitting patients who have deteriorated and developed neuro signs and symptoms between relapses
- 65% relapsing remitting patients progress
- gait and bladder disorders
5
Q
Primary progressive multiple sclerosis:
A
- 10%
- progressive deterioration from onset
- more common in older
6
Q
MS symptoms:
A
- non specific e.g. significant lethargy
- visual
- sensory
- motor
- cerebellar
- other: urinary incontinence, sexual dysfunction, intellectual deterioration
7
Q
MS visual symptoms:
A
- optic neuritis: most common presenting feature
- optic atrophy
- Uhtoff’s phenomenon
- internuclear ophthalmoplegia
8
Q
MS sensory symptoms:
A
- pins/needles
- numbness
- trigeminal neuralgia
- Lhermitte’s syndrome: paraesthesiae in limbs on neck flexion
9
Q
MS motor symptoms:
A
spastic weakness: most common in legs
10
Q
MS cerebellar symptoms:
A
- ataxia (more in acute relapse)
- tremor
11
Q
Investigations of MS:
A
MRI: -high signal T2 lesions -periventricular plaques -Dawson fingers - hyperintense lesions perpendicular to corpus callosum CSF -oligoclonal bands (not in serum) -increased intrathecal synthesis of IgG Visual evoked potentials -delayed but well preserved waveform
12
Q
Treatment of acute MS relapse:
A
- high dose steroids (e.g. oral or IV methylprednisolone)
- 5 days to shorten length of acute relapse
- does not alter degree of recovery
13
Q
Disease modifying drugs used in MS:
A
- beta interferon to reduce relapses with certain criteria
- glatiramer acetate - immunomodulating drug
- natalizumab - recombinant monoclonal Ab which antagonises alpha-4 beta-1 integrin on leucocytes so no migration across BBB
- fingolimod: sphingosine 1-phosphate receptor modulator prevents lymphocytes leaving lymph nodes
14
Q
Drugs used for spasticity in MS:
A
- baclofen and gabapentin
- other: diazepam, dantrolene and tizanidine
- physiotherapy
15
Q
Drugs used for bladder dysfunction in MS:
A
- intermittent self-catheterisation if significant residual volume
- anticholinergics may improve urinary frequency